Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Akiko Izawa"'
Autor:
Hideki Narumi, Katsuyuki Mori, Masashi Uchida, Tomohiko Suzuki, Tadatsugu Taniguchi, Yoshiaki Tsushima, Hiromi Tsuchiyama, Tomokatsu Iwamura, Kazumi Nishimura, Kiyoshi Okano, Shinobu Momen, Asano Tomomi, Yamashita Yuji, Akiko Izawa, Koji Yamashita, Hideyuki Yanai
Publikováno v:
Cancer Science
Malignant ascites manifests as an end-stage event during the progression of a number of cancers and lacks a generally accepted standard therapy. Interferon-β (IFN-β) has been used to treat several cancer indications; however, little is known about
Publikováno v:
Bioorganicmedicinal chemistry. 26(8)
Dolastatin 10 (1) is a highly potent cytotoxic microtubule inhibitor (cytotoxicity IC50
Autor:
Yasushi Miyauchi, Saburo Sone, Hiromi Tsuchiyama, Akiko Izawa, Kazuki Ando, Yuichi Torii, Tomohiko Suzuki, Natsumi Takemi, Jun-Ichi Tanabe
Publikováno v:
Immunology. 122:562-570
Type I interferons (IFNs), IFN-alpha and IFN-beta, are widely used for treating chronic hepatitis C. Although retrospective studies have suggested that type I IFNs have direct antifibrotic effects, little is known about these mechanisms. The present
Publikováno v:
Hepatology Research. 37:121-126
We studied the effect of combination therapy consisting of IFN-β and ribavirin on mouse hepatitis virus (MHV) infection in mice. It was found that the combination of IFN-α and ribavirin was more effective in increasing survival time than IFN-α tre
Autor:
Akiko Izawa, Norifumi Kawada, Saeko Funamoto, Hideo Akiyama, Mie Kainoh, Tomohiko Suzuki, Rieko Shimozono, Kana Kunita, Takafumi Sai, Kazumi Nishimura
The results of clinical and experimental studies suggest that type I interferons (IFNs) may have direct antifibrotic activity in addition to their antiviral properties. However, the mechanisms are still unclear; in particular, little is known about t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa3b57b6fa68b6d28d427c24dbe1a047
https://europepmc.org/articles/PMC4490747/
https://europepmc.org/articles/PMC4490747/
Autor:
Yasushi Miyauchi, Kohei Ueda, Arata Azuma, Shu Hashimoto, Ying-Ji Li, Shinji Abe, Saburo Sone, Shoji Kudoh, Satoshi Henmi, Jiro Usuki, Akiko Izawa, Kuniko Matsuda
Publikováno v:
American Journal of Respiratory Cell and Molecular Biology. 32:93-98
Pulmonary fibrosis is the result of abnormal processes of repair that occur after lung injury. Transforming growth factor (TGF)-beta is a key molecule in the progression of pulmonary fibrosis. Although clinical use of interferon (IFN)-beta did not im
Publikováno v:
STEM CELLS. 19:71-79
Delta-like (dlk) is a family of transmembrane proteins containing epidermal growth factor-like repeat motifs homologous to the notch/delta/serrate family. Recent studies suggest that dlk is a negative regulator of adipocyte differentiation, a promoti
Autor:
Akiko Izawa, Jun Sese
Publikováno v:
Source Code for Biology and Medicine
Background The whole-genome sequences of many non-model organisms have recently been determined. Using these genome sequences, next-generation sequencing based experiments such as RNA-seq and ChIP-seq have been performed and comparisons of the experi
Effects of natural human interleukin-6 on thrombopoiesis and tumor progression in tumor-bearing mice
Autor:
Akiko Izawa, Nobutaka Ida, Tasuku Okamoto, Masanobu Naruto, Yu-ichiro Satoh, Ken-ichi Yoshizawa, Keiko Moriya
Publikováno v:
Cancer Letters. 79:83-89
The growth of inoculated colon 26 adenocarcinoma (colon 26) in mice gradually increased the platelet count owing to murine IL-6 secreted from the tumor, while Lewis lung carcinoma (LLC) decreased the platelet count in the hosts, depending on the tumo
Autor:
Saburo, Sone, Akiko, Izawa, Hideki, Narumi, Akemi, Kajita, Junichi, Tanabe, Fumihiro, Taguchi
Publikováno v:
Hepatology research : the official journal of the Japan Society of Hepatology. 37(2)
To determine the differences in efficacy between therapy using IFN-beta and ribavirin, and using IFN-alpha and ribavirin.We studied the effect of combination therapy consisting of IFN-beta and ribavirin on mouse hepatitis virus (MHV) infection in mic